These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6276431)

  • 1. Phosphodiesterase activity in human subcutaneous adipose tissue in hyper- and hypothyroidism.
    Engfeldt P; Arner P; Bolinder J; Wennlund A; Ostman J
    J Clin Endocrinol Metab; 1982 Mar; 54(3):625-9. PubMed ID: 6276431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of hyper- and hypothyroidism on subcutaneous adipose tissue blood flow in man.
    Wennlund A; Linde B
    J Clin Endocrinol Metab; 1984 Aug; 59(2):258-62. PubMed ID: 6736204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase activity in human subcutaneous adipose tissue in insulin- and noninsulin-dependent diabetes mellitus.
    Engfeldt P; Arner P; Bolinder J; Ostman J
    J Clin Endocrinol Metab; 1982 Nov; 55(5):983-8. PubMed ID: 6288760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by thyroid status of hepatic low Km phosphodiesterase.
    Morgan DW; Shaheen O; Keyes WG; Heimberg M
    Endocrinology; 1982 Jan; 110(1):260-4. PubMed ID: 6274622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hyperthyroidism and hypothyroidism on human red blood cell Ca2+-ATPase activity.
    Dube MP; Davis FB; Davis PJ; Schoenl M; Blas SD
    J Clin Endocrinol Metab; 1986 Feb; 62(2):253-7. PubMed ID: 2934403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte sodium/potassium adenosine triphosphatase in thyroid disease and nonthyroidal illness.
    Dasmahapatra A; Cohen MP; Grossman SD; Lasker N
    J Clin Endocrinol Metab; 1985 Jul; 61(1):110-5. PubMed ID: 2987290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased erythrocyte catalase activity in patients with hyperthyroidism.
    Kurasaki M; Saito T; Kaji H; Kojima Y; Saito K
    Horm Metab Res; 1986 Jan; 18(1):56-9. PubMed ID: 3949283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
    Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
    J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
    Akin F; Yaylali GF; Turgut S; Kaptanoglu B
    Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of experimental hypo- and hyperthyroidism on serum adiponectin.
    Aragão CN; Souza LL; Cabanelas A; Oliveira KJ; Pazos-Moura CC
    Metabolism; 2007 Jan; 56(1):6-11. PubMed ID: 17161219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. gamma-Glutamyl transpeptidase levels in thyroid disease.
    Azizi F
    Arch Intern Med; 1982 Jan; 142(1):79-81. PubMed ID: 6119059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evolution of serum gammaglutamyl transpeptidase activity in treated hyperthyroid and hypothyroid patients].
    Couzigou P; Latapie JL; Fleury B; Climas MT; Le Moigne F; Crockett E; Sauneron MF; Richard-Molard B; Amouretti M; Béraud C
    Gastroenterol Clin Biol; 1984 May; 8(5):458-63. PubMed ID: 6145651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of insulin and lipolytic hormones on cyclic AMP phosphodieterase activity in normal and diabetic rat adipose tissue.
    Solomon SS
    Endocrinology; 1975 Jun; 96(6):1366-73. PubMed ID: 165058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum bone Gla protein (BGP) during treatment of hyperthyroidism and hypothyroidism. A longitudinal study.
    Faber J; Perrild H; Johansen JS
    Horm Metab Res; 1991 Mar; 23(3):135-8. PubMed ID: 1864560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients.
    Nedvídková J; Felt V
    Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of triiodothyronine uptake by erythrocytes in hyperthyroidism, hypothyroidism, and thyroid hormone resistance.
    Holm AC; Kågedal B
    J Clin Endocrinol Metab; 1989 Aug; 69(2):364-8. PubMed ID: 2753979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual plasma ghrelin changes in the same patients in hyperthyroid, hypothyroid and euthyroid state.
    Ruchala M; Gurgul E; Stangierski A; Wrotkowska E; Moczko J
    Peptides; 2014 Jan; 51():31-4. PubMed ID: 24184592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inverse relationship between serum dopamine-beta-hydroxylase activity and thyroid function.
    Stolk JM; Hurst JH; Nisula BC
    J Clin Endocrinol Metab; 1980 Aug; 51(2):259-64. PubMed ID: 7400296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of serum angiotensin-I-converting enzyme in patients with thyroid disorders.
    Reiners C; Gramer-Kurz E; Pickert E; Schweisfurth H
    Clin Physiol Biochem; 1988; 6(1):44-9. PubMed ID: 2834132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.